Charles Schwab’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88M | Sell |
382,389
-26,116
| -6% | -$265K | ﹤0.01% | 2435 |
|
|
2025
Q1 | $2.28M | Sell |
408,505
-9,450
| -2% | -$52.7K | ﹤0.01% | 2567 |
|
|
2024
Q4 | $3.37M | Buy |
417,955
+7,726
| +2% | +$62.3K | ﹤0.01% | 2518 |
|
|
2024
Q3 | $4.2M | Buy |
410,229
+247,863
| +153% | +$2.54M | ﹤0.01% | 2458 |
|
|
2024
Q2 | $1.15M | Buy |
162,366
+57,822
| +55% | +$409K | ﹤0.01% | 2878 |
|
|
2024
Q1 | $1.44M | Sell |
104,544
-2,057
| -2% | -$28.3K | ﹤0.01% | 2685 |
|
|
2023
Q4 | $981K | Buy |
106,601
+719
| +0.7% | +$6.62K | ﹤0.01% | 2840 |
|
|
2023
Q3 | $641K | Hold |
105,882
| – | – | ﹤0.01% | 2953 |
|
|
2023
Q2 | $822K | Buy |
105,882
+89,229
| +536% | +$692K | ﹤0.01% | 2831 |
|
|
2023
Q1 | $94.9K | Hold |
16,653
| – | – | ﹤0.01% | 3255 |
|
|
2022
Q4 | $98.1K | Hold |
16,653
| – | – | ﹤0.01% | 3262 |
|
|
2022
Q3 | $54K | Sell |
16,653
-127,664
| -88% | -$414K | ﹤0.01% | 3315 |
|
|
2022
Q2 | $647K | Sell |
144,317
-71,196
| -33% | -$319K | ﹤0.01% | 2965 |
|
|
2022
Q1 | $1.15M | Sell |
215,513
-8,918
| -4% | -$47.6K | ﹤0.01% | 2798 |
|
|
2021
Q4 | $3.3M | Buy |
224,431
+4,776
| +2% | +$70.2K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $4.59M | Buy |
219,655
+88,840
| +68% | +$1.86M | ﹤0.01% | 2416 |
|
|
2021
Q2 | $2.32M | Buy |
130,815
+16,312
| +14% | +$289K | ﹤0.01% | 2665 |
|
|
2021
Q1 | $2.81M | Buy |
114,503
+4,790
| +4% | +$117K | ﹤0.01% | 2550 |
|
|
2020
Q4 | $3.71M | Buy |
109,713
+56,837
| +107% | +$1.92M | ﹤0.01% | 2360 |
|
|
2020
Q3 | $1.32M | Sell |
52,876
-846
| -2% | -$21.2K | ﹤0.01% | 2616 |
|
|
2020
Q2 | $1.81M | Buy |
+53,722
| New | +$1.81M | ﹤0.01% | 2458 |
|